We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 50

The issues 2013: upcoming legal topics in the Czech Republic

  • CMS Cameron McKenna
  • -
  • Czech Republic
  • -
  • February 1 2013

The adoption of the new Civil Code and the Act on Corporations, effective as of 1 January 2014, is a step of great importance for the Czech law. There

UK private healthcare sector under the microscope

  • Dentons
  • -
  • United Kingdom
  • -
  • December 22 2011

On 8 December 2011, the Office of Fair Trading in the UK announced that it has sufficient concerns about the way in which the market for private healthcare services operates to be considering making a market investigation reference to the Competition Commission

Health care insurance companies in Italy fined over 13 million for anti-competitive behaviour

  • McDermott Will & Emery
  • -
  • Italy
  • -
  • October 11 2011

The Italian Competition Authority has found that four health care insurance providersHDI-Gerling Industrie Versicherung AG, Faro Compagnia di Assicurazioni e riassicurazioni S.p.a., Navale Assicurazioni, and Primogest (a multi-firm agency)participated in anti-competitive behaviour between 2003 and 2008

2010 year in review: key legal and regulatory developments

  • Allen & Gledhill LLP
  • -
  • Singapore
  • -
  • December 28 2010

In this last issue for the year 2010, the Allen & Gledhill Legal Bulletin provides an overview of the key developments in 2010

Repeal of antitrust exemption gains traction as House and Senate Democrats reconcile healthcare reform bills

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • January 8 2010

U.S. House Representatives Peter DeFazio, (D-OR) and Gene Taylor (D-MS) drafted a letter to House Speaker Nancy Pelosi (D-CA) in support of repealing the antitrust exemption under the McCarran Ferguson Act for health insurers and medical liability insurers

Do not pass go, do not collect $200: Michigan statute and regulatory order banning MFN provisions in provider contracts ends government antitrust lawsuit against Michigan Blue

  • Baker & Hostetler LLP
  • -
  • USA
  • -
  • March 26 2013

In the wake of the passage of a Michigan statute and regulatory order banning the use of most favored nation ("MFN") clauses by insurers, health

US Department of Justice challenges use by Blue Cross of most favored nation contracts

  • Mayer Brown LLP
  • -
  • USA
  • -
  • October 28 2010

The Antitrust Division of the US Department of Justice ("DOJ") has challenged the use of "most favored nation" clauses by an alleged dominant health insurer, contending that contracts guaranteeing a buyer the lowest price may exclude competition

BUPA loses Irish state aid appeal

  • Shepherd & Wedderburn LLP
  • -
  • European Union, Ireland
  • -
  • February 29 2008

On 12 February, the Court of First Instance (CFI) issued its judgment in Case T-28903, dismissing an application by BUPA to annul a decision of the European Commission (the Commission) in respect of a risk equalisation system for the private medical insurance sector in Ireland

DOJ approves UnitedHealth-Sierra merger, subject to divestitures

  • Squire Sanders
  • -
  • USA
  • -
  • March 20 2008

The DOJ has agreed to allow the largest health insurer in the United States, UnitedHealth Group, to proceed with its planned US$2.6 billion acquisition of Sierra Health Services Inc., subject to the condition that UnitedHealth divest its Medicare Advantage policyholders and related assets in the Las Vegas area

Legislation introduced to eliminate federal antitrust exemption for health insurance and medical malpractice insurance companies

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • September 17 2009

Today, Senate Judiciary Committee Chairman Patrick Leahy introduced legislation to eliminate the federal antitrust exemption for health insurance and medical malpractice insurance companies